Pharmacokinetics of cefotaxime and desacetylcefotaxime in patients with liver disease.

The dispositions of cefotaxime and its metabolite desacetylcefotaxime were investigated in patients with different forms of chronic parenchymal liver disease (CPLD). A total of 31 subjects (27 patients and 4 controls) received a single 2-g dose of cefotaxime by infusion, and serial blood samples wer...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Ko, R J, Sattler, F R, Nichols, S, Akriviadis, E, Runyon, B, Appleman, M, Cohen, J L, Koda, R T
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1991
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245175/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1929296/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.7.1376
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!